Michelle Tharp
Nurse Practitioner · Jackson, MSNPI 1720528011
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (44.6%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Biomarin Pharmaceutical Inc. accounts for 69.1% of it on its own, with 13 other manufacturers making up the rest. 2025 is the largest year on record at $21,864, more than ten times the $250 reported in 2022. Among nurse practitioner clinicians in MS with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 77 payments — averaging $357.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biomarin Pharmaceutical Inc.$19K
- Sanofi$5K
- PTC Therapeutics, Inc.$1K
- Chiesi USA, Inc.$1K
- AbbVie$125
- Takeda Pharmaceuticals U.S.A., Inc.$108
- plus $299 from 8 others
What the payments were for
- Consulting fees$6,87825%
- Speaking & faculty fees$12,29045%
- Travel & lodging$6,55424%
- Food & beverage$1,8087%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biomarin Pharmaceutical Inc. | 34 | $19,019 |
| Sanofi | 17 | $5,177 |
| PTC Therapeutics, Inc. | 5 | $1,441 |
| Chiesi USA, Inc. | 5 | $1,360 |
| AbbVie | 1 | $125 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $108 |
| Ultragenyx Pharmaceutical Inc. | 3 | $69 |
| Cycle Pharmaceuticals Inc | 2 | $62 |
| Orchard Therapeutics North America | 1 | $44 |
| Zevra Therapeutics Inc | 1 | $43 |
| Mirum Pharmaceuticals, Inc. | 1 | $24 |
| Amicus Therapeutics, Inc. | 1 | $23 |
| Recordati_rare_diseases_inc. | 1 | $19 |
| Intrabio Inc | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$27,530 in reported general payments places this provider in the 95th percentile of 1,090 nurse practitioner providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RavictiGlycerol Phenylbutyrate | 12 | $401,628 |
| Sapropterin Dihydrochloride | 18 | $85,779 |
| Azithromycin | 11 | $27 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Jackson
- Jo Anna WarrenJackson$73K
- Jennifer HollyJackson$16K
- Brandon ChambersJackson$12K
- Ramona BallJackson$9K
- Bonney SimmonsJackson$9K
- Catherine WellsJackson$9K
- Tamecia HerbertJackson$8K
- Amy HeidelbergJackson$7K
- Amy LemlyJackson$6K
- Jennifer PateJackson$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.